供应商 · 研究机构 · 发现——同类成熟企业

CRVAB GROUP

CRVAB集团是一家来自中国的领先酶和益生菌制造商，总部位于北京，工厂位于内蒙古赤峰。赤峰工厂年产能超过30,000吨，产品涵盖饲料级和食品级。工厂建立了自己的质量控制和质量保证体系，获得ISO9001、ISO22000、FAMI-QS和FSSC22000认证。CRVAB研发实力雄厚，拥有2个独立研发中心，获得21项中国国家级专利。如今，产品出口到亚洲、非洲、欧洲、北美和南美的30多个国家。现在，我们正在南美市场寻找合作伙伴。让我们携手合作！ CREAZYME酶制剂（饲料和食品级）：植酸酶、木聚糖酶、β-甘露聚糖酶、β-葡聚糖酶、α-半乳糖苷酶、葡萄糖氧化酶、溶菌酶、纤维素酶、淀粉酶、蛋白酶、脂肪酶、果胶酶和复合酶 VAPRO益生菌（饲料和食品级）：枯草芽孢杆菌、地衣芽孢杆菌、凝结芽孢杆菌、解淀粉芽孢杆菌、丁酸梭菌、植物乳杆菌、嗜酸乳杆菌、屎肠球菌、粪肠球菌、人用益生菌、家禽用 …

运营中中国亚洲成立 2009 未上市员工: 4 核实于 2026-10-05

简介

CRVAB Bio-tech Group (CRVAB GROUP; “Create Value Biology”) is a biotechnology company specializing in large-scale fermentation R&D and manufacturing of probiotics, enzymes, and related products, integrating R&D, production, QA/QC, and trading; it sells globally to feed/food and other industries. Founded in 2009 and headquartered in Beijing (Daxing District address given) with a manufacturer base in Chifeng, Inner Mongolia. Core products include feed/food enzymes (e.g., phytase, xylanase, β-mannanase, β-glucanase, α-galactosidase, amylase, protease) and VAPRO probiotics (multiple Bacillus, Lactobacillus, Enterococcus; plus human/poultry/livestock/pet/water probiotics). Chifeng factory is described as >30,000 MT/year capacity and also as 50,000 MT/year elsewhere; it has ISO9001/HACCP/ISO22000/FAMI-QS/FSSC22000-type systems and certifications. R&D scale: two independent R&D centers and 21 national patents are stated. Key partnership: Kemin Industries; a 2019 joint venture investment (up to 300 million RMB) to expand an Inner Mongolia enzyme/probiotics production base, with a focus on GI health solutions. Latest 2025-2026 developments: a 2026-06-26 LinkedIn listing exists; no specific 2025-2026 revenue, employee count, investors/stock listing, or funding rounds are provided, though it’s described as privately held and active at least as of 2026-06-26.

Sources#

行业: 饲料, 食品配料, 工业化学, 种子与遗传育种, 纺织与皮革
主题: 酶与生物催化, 益生菌与发酵菌种, 动物饲料与饲料添加剂, 畜禽生产与遗传育种
角色: 研究机构 — “…tup includes a postdoctoral research station, two research centers (Beijing and Nanjing), and diverse R&D/engi…”
为何属于生物经济: CRVAB GROUP 是北京的生物技术公司，以发酵制造酶和益生菌（饲料和食品级）并维护质控体系——在内蒙古赤峰设有生产基地。
发现途径: VTR Biotech 溢多利 (SZ 300381); Vland Biotech 蔚蓝生物 (SSE 603739); Yiming Biotechnology; Amano Enzyme

供应的生物解决方案 0

尚未被列为已评级方案的供应商。

产品与服务

子公司: Inner Mongolia CRVAB Bio-technology Co., Ltd. · Hongkong subsidiary

新闻与状态 6

2024-10 最新状态: 公司参加了2024年10月的FIGAP展会。 ↗ ↗ ↗
2026-04-18 科为博
CRVAB GROUP (科为博生物集团) hosted a client appreciation banquet in Nanchang during the China Feed Industry Exhibition, introducing its new Antibacterial Shield series, emphasizing technology-driven solutions, quality, and collaborative growth with partners for …
2025-11-20 科为博
The article reports that CRVAB Group (科为博集团) Chairman Wu Peijun was re-elected as the rotating chairman (轮值会长) of the Beijing Feed Industry Association for the ninth term, signaling continued leadership and commitment to advancing high-quality development in …
2025-05-23 科为博
CRVAB GROUP (科为博) is highlighted as a trusted leader in the Chinese animal husbandry bioindustry, with its chairman elected to serve as president of the China Animal Husbandry Association’s Bio Industry Branch, signaling industry recognition and influence. The …
2025-07-28 科为博
CRVAB GROUP (科为博集团) is highlighted as the star partner of the Fifth Ruminant Feed Conference, receiving the “Starlit Strategic Partner” honor for five years of collaboration with the event, and is presented as a leading contributor to the ruminant industry …
2026-02-13 Dấu ấn Tất niên AMAVET 2025: Đoàn kết - Trí tuệ - Trái tim
CRVAB GROUP is listed as one of the strategic providers acknowledged and honored by AMAVET during the 2025 year-end event, reflecting a strong, ongoing partnership with AMAVET. This recognition underscores CRVAB GROUP’s role as a valued collaborator …
2025-01-14 UAlbany’s Thomas Bartlett: Studying Bacterial Cell Shape and Growth | University at Albany
CrvAB is a bacterial cytoskeletal complex discovered in Vibrio cholerae that patterns the growth of the curved cell shape, enabling the bacterium to navigate the gut and invade the host intestinal lining.

关系网络：股东、合作伙伴、同类

股权与投资方 2

子公司	Inner Mongolia CRVAB Bio-technology Co., Ltd
子公司	Hongkong subsidiary

合作与交易 2

交易对手	Kemin Industries …The company participated in the FIGAP exhibition in October 2024.…
合资企业	CRVAB formed a joint venture …ith a mission to leverage science and technology as core drivers. In 2019, CRVAB formed a joint venture with Kemin Industries to invest up to 300 million RMB in an Inner Mongolia production bas…

身份与联系方式

联系方式、人员和法律信息仅向会员开放。

会员登录